Results 251 to 260 of about 386,471 (278)
Some of the next articles are maybe not open access.
Potential Role of Muscarinic Agonists in Alzheimerʼs Disease
Drugs & Aging, 1997Alzheimer's disease (AD) is a common neurodegenerative disorder and a leading cause of death among the elderly. Recent advances in our understanding of the neurobiology of AD have provided scientific groundwork for the development of potentially more effective and less toxic treatment strategies for the disease.
Laura D. Baker+2 more
openaire +3 more sources
Journal of Medicinal Chemistry, 1998
Muscarinic agonists were tested in two models indicative of clinical antipsychotic activity: conditioned avoidance responding (CAR) in rats and inhibition of apomorphine-induced climbing in mice.
P. Sauerberg+14 more
semanticscholar +1 more source
Muscarinic agonists were tested in two models indicative of clinical antipsychotic activity: conditioned avoidance responding (CAR) in rats and inhibition of apomorphine-induced climbing in mice.
P. Sauerberg+14 more
semanticscholar +1 more source
, 1991
The synthesis of quinuclidine and azanorbornyl pyrazine derivatives has yielded highly potent and efficacious muscarinic agonists; chloro-substitution in the pyrazine ring of the quinuclidine analogue resulted in the formation of a derivative with both ...
R. Baker+3 more
semanticscholar +1 more source
The synthesis of quinuclidine and azanorbornyl pyrazine derivatives has yielded highly potent and efficacious muscarinic agonists; chloro-substitution in the pyrazine ring of the quinuclidine analogue resulted in the formation of a derivative with both ...
R. Baker+3 more
semanticscholar +1 more source
Journal of Medicinal Chemistry, 2001
Selective muscarinic agonists could be useful in the treatment of neurological disorders such as Alzheimer's disease, schizophrenia, and chronic pain. Many muscarinic agonists have been developed, yet most exhibit at best limited functional selectivity ...
W. G. Rajeswaran+11 more
semanticscholar +1 more source
Selective muscarinic agonists could be useful in the treatment of neurological disorders such as Alzheimer's disease, schizophrenia, and chronic pain. Many muscarinic agonists have been developed, yet most exhibit at best limited functional selectivity ...
W. G. Rajeswaran+11 more
semanticscholar +1 more source
Journal of Medicinal Chemistry, 2003
Muscarinic agonists might be useful in the treatment of neurological disorders, including Alzheimer's disease, schizophrenia, chronic pain, and drug abuse.
Yang Cao+10 more
semanticscholar +1 more source
Muscarinic agonists might be useful in the treatment of neurological disorders, including Alzheimer's disease, schizophrenia, chronic pain, and drug abuse.
Yang Cao+10 more
semanticscholar +1 more source
Characterization of muscarinic agonists in recombinant cell lines
Life Sciences, 1993Using recombinant CHO cells that express Hm1-Hm5 receptors, reference muscarinic agonists have been characterized with respect to their activity in receptor binding and second messenger assays. In whole cell [3H]-N-methyl scopolamine binding, no agonist was found to be truly subtype selective, although some showed marked differences between several of ...
Anthony Jerome Thomas+5 more
openaire +3 more sources
Effects of muscarinic agonists in the guinea‐pig prostate
Autonomic and Autacoid Pharmacology, 2007Summary1 The contractile response to transmural stimulation of the guinea‐pig prostate is largely due to activation of noradrenergic neurons but there is a small contribution from cholinergic neurons. Carbachol and acetylcholine have been reported to act via muscarinic M1cholinoceptors to facilitate contractions produced by neuronal stimulation of the ...
openaire +3 more sources
Journal of Receptor and Signal Transduction Research, 2010
Fabiola Pláceres Uray+3 more
semanticscholar +1 more source
Fabiola Pláceres Uray+3 more
semanticscholar +1 more source
Structural Determinants of Muscarinic Agonist Activity
1989Traditionally, structure-activity relationships (SAR) among muscarinic cholinergic agonists have been derived from dose-effect studies on isolated tissues or in whole animals (Barlow, 1964). In general, in vitro assays are preferable to in vivo assays for studying relations between chemical structure and actual effect (pharmacodynamics).
openaire +2 more sources